Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2015

Every FDA drug recall initiated in 2015, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,733 recalls, newest first.

Class III · Low risk

Prednisone 20 mg

Labeling: Not elsewhere classified. NDC number is incorrect on the container.

Terminated Labeling / mix-up Northwind Pharmaceuticals LLC NDC 51655-320-53 D-0485-2016
Class I · High risk

Vitamin Supplement

Superpotent Drug: The vitamin supplement contains an extremely high level of vitamin D3 (Cholecalciferol).

Ongoing Wrong potency / content Glades Drugs Inc. D-0669-2016
Class III · Low risk

Paricalcitol Capsules

Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules.

Terminated Failed specification Dr. Reddy's Laboratories, Inc. NDC 55111-665-30 D-0721-2016
Class III · Low risk

Paricalcitol Capsules

Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules.

Terminated Failed specification Dr. Reddy's Laboratories, Inc. NDC 55111-664-30 D-0720-2016
Class III · Low risk

Paricalcitol Capsules

Failed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Paricalcitol capsules.

Terminated Failed specification Dr. Reddy's Laboratories, Inc. NDC 55111-663-30 D-0719-2016
Class III · Low risk

Epsom Salt

Failed Impurities/Degradation Specifications: Level of iron exceeds the limit set by the USP monograph for it (USP limit is NMT 0.5 ug/g (ppm)).

Terminated Impurity / degradation PQ Corporation D-0564-2016
Class II · Moderate risk

Kindest Kare Antimicrobial Foaming Handwash

Labeling: Not Elsewhere Classified; Incorrect/Undeclared Excipients: Outdated previous version of label applied to products that incorrectly states one inactive ingredient.

Terminated Labeling / mix-up Steris Corp NDC 0519-1452-13 D-0518-2016
Class II · Moderate risk

GRx HiCort 25

Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.

Terminated Unapproved drug Geritrex Corp NDC 54162-015-12 D-0392-2016
Class II · Moderate risk

Carbo-O-Philic 40 Gel 40%

Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.

Terminated Unapproved drug Geritrex Corp NDC 54162-016-15 D-0391-2016
Class II · Moderate risk

Carbo-O-Philic 40 Cream 40%

Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.

Terminated Unapproved drug Geritrex Corp NDC 54162-640-03 D-0390-2016

Recalls by year